Ab Interno Gelatin Microstent With MMC vs. Trabeculectomy With MMC: 3 Year Retrospective Cohort Analysis

NCT05126069 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 242

Last updated 2021-11-18

No results posted yet for this study

Summary

To compare 3-year post-operative efficacy and safety of standalone ab interno gelatin microstent (Xen45®) versus trabeculectomy.

Conditions

  • Filtering Surgery
  • Trabeculectomy

Interventions

DEVICE

Ab interno gelatin microstent

Ab interno gelatin microstent

PROCEDURE

Trabeculectomy

Trabeculectomy

Sponsors & Collaborators

  • Prism Eye Institute

    lead OTHER

Eligibility

Min Age
30 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-08-21
Primary Completion
2019-05-01
Completion
2020-08-28
FDA Device
Yes

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05126069 on ClinicalTrials.gov